Companies similar to Amgen (AMGN)
Health Care · NASDAQ
Amgen (AMGN)'s closest peers include AbbVie (ABBV), Bristol Myers Squibb (BMY), Lilly (Eli) (LLY), Gilead Sciences (GILD), Johnson & Johnson (JNJ), Merck & Co. (MRK), NOVARTIS AG (NVS) and Pfizer (PFE). This peer set is drawn from AMGN's enriched company profile and is informational only — not financial advice.
Similar companies
-
AbbVieABBVHealth Care
Global biopharmaceutical company with leadership positions in immunology, neuroscience, oncology, and aesthetics targeting complex diseases.
$256.10 (as of 2026-07-21) · market cap $447.7B
-
Bristol Myers SquibbBMYHealth Care
Bristol Myers Squibb is a leading biopharmaceutical company specializing in advanced oncology, immunology, and cardiovascular therapies using diverse…
$60.93 (as of 2026-07-21) · market cap $123.2B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,175.41 (as of 2026-07-21) · market cap $1.08T
-
Gilead SciencesGILDHealth Care
A diversified biopharmaceutical company pioneering viral disease treatments, cell therapies, and oncology medicines with a portfolio spanning HIV, hepatitis,…
$130.28 (as of 2026-07-21) · market cap $161.3B
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$250.61 (as of 2026-07-21) · market cap $603.9B
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$126.26 (as of 2026-07-21) · market cap $308.5B
-
NOVARTIS AGNVS
Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
$153.87 (as of 2026-07-21) · market cap $228.2B
-
PfizerPFEHealth Care
Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular,…
$24.94 (as of 2026-07-21) · market cap $141.5B
Not quite? Describe exactly what you want →
Peers are drawn from AMGN's enriched profile (the same similarity signal the chat uses for "companies like AMGN"). See the full profile: Amgen (AMGN).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.